GUANZE MEDICAL (02427) announced its annual results for the period ending December 31, 2025. Revenue amounted to RMB88.45 million, representing a decrease of 43.2% compared to the previous year. The loss attributable to the company's owners was RMB29.72 million, a significant shift from a profit of RMB17.20 million in the same period last year. The basic loss per share was RMB0.03. The decline in total annual revenue was primarily due to reduced sales of medical imaging film products and medical imaging cloud services.